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The Sestrins constitute a family of evolutionarily conserved stress-inducible proteins that suppress oxidative
stress and regulate AMP-dependent protein kinase (AMPK)-mammalian target of rapamycin (mTOR)
signaling. By virtue of these activities, the Sestrins serve as important regulators of metabolic homeostasis.
Accordingly, inactivation of Sestrin genes in invertebrates resulted in diverse metabolic pathologies,
including oxidative damage, fat accumulation, mitochondrial dysfunction, and muscle degeneration, that
resemble accelerated tissue aging. Likewise, Sestrin deficiencies inmice led to accelerated diabetic progres-
sion upon obesity. Further investigation of Sestrin function and regulation should provide new insights into
age-associated metabolic diseases, such as diabetes, myopathies, and cancer.Introduction
Sestrins are highly conserved proteins encoded by genes whose
expression is upregulated in cells exposed to a variety of envi-
ronmental stresses, including DNA damage, oxidative stress,
and hypoxia. Sestrins are universally found throughout the ani-
mal kingdom, but no Sestrin homologs were identified in plants
or fungi. Most vertebrates, including mammals, express three
Sestrins (Sesn1, Sesn2, and Sesn3), while most invertebrate
genomes contain only a single Sestrin (Sesn) gene. Mammalian
Sestrins are encoded by three independent genomic loci,
Sesn1, Sesn2, and Sesn3, and the Sesn1 and Sesn3 genes are
subject to alternative splicing, thus generating several Sestrin
proteins (Peeters et al., 2003). It has been challenging to identify
biochemical functions associated with the Sestrins, partially
because the proteins do not contain any known structural
domains or catalytic motifs. Only a very distant sequence homol-
ogy to bacterial oxidoreductases was detected, which led to
discovery of Sestrins’ antioxidant function (Budanov et al.,
2004). Sestrins also bind to Keap1 and p62/sequestosome
(SQSTM), and thereby suppress autophagic degradation of
Keap1 and lead to enhanced Nrf2-dependent antioxidant gene
transcription (Bae et al., 2013). Independently of these redox-
regulating activities, Sestrins can suppress mammalian target
of rapamycin complex 1 (mTORC1) activity through the activa-
tion of AMP-dependent protein kinase (AMPK) (Budanov and
Karin, 2008; Chen et al., 2010; Lee et al., 2010). Sestrins are
able to bind AMPK, and through direct physical association, as
well as through indirect transcriptional regulation, stimulate for-
mation of the AMPK holoenzyme and its phosphorylation and
activation by upstream kinases such as LKB1 (Budanov and
Karin, 2008; Chen et al., 2010). However, the exact biochemical
mechanisms through which the Sestrins function as antioxidants
or as AMPK activators are unclear; protein structure determina-
tion through X-ray crystallography or nuclear magnetic reso-
nance (NMR) would provide better clues on the physicochemical792 Cell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc.basis of Sestrins function. Although a lot of work is still needed to
reveal the detailed molecular functions of the Sestrins, genetic
studies have clearly shown that the Sestrins maintain metabolic
homeostasis and protect cells and organisms from age-related
physiological abnormalities, mainly through regulation of the
AMPK-TORC1 axis. Although most of the data describing the
antiaging functions of Sestrins were initially obtained from
dSesn-deficient Drosophila (Lee et al., 2010), recent results
from knockout (KO) mouse strains deficient in Sesn2 and
Sesn3 support the critical role of Sestrins in regulation of meta-
bolism and suppression of age- and obesity-associated meta-
bolic disorders (Bae et al., 2013; Lee et al., 2012a). Furthermore,
a recent study usingC. elegans shows that cSesn is an important
regulator of healthspan and lifespan in worms (Yang et al., 2013),
suggesting that Sestrins’ antiaging function is evolutionarily
conserved throughout the animal kingdom. In this review, we
will discuss the physiological functions of the Sestrins, with an
emphasis on the regulation of metabolism and aging.
Regulation of Sestrin Expression
In response to diverse insults, cells adjust their metabolic
timbre to support cellular adaptation to stress (for example, by
facilitating damage repair, ceasing anabolic processes, and
stimulating catabolic reactions). Through these adjustments,
cells can prevent accumulation of damaged macromolecules
and save scarce resources for diverse repair processes.
Because Sestrins expression is stress inducible (Budanov
et al., 2002; Velasco-Miguel et al., 1999), the Sestrins can be
involved in cellular- or organism-level adaptation to diverse
metabolic challenges. It is therefore critical to understand how
Sestrin expression is regulated under diverse physiological and
pathological contexts.
Genotoxic Stress
Dysregulation of different metabolic pathways can lead to
release of genotoxic compounds that damage DNA, such as
Figure 1. Regulation of Oxidative Metabolism by Sestrin-Family
Proteins
(A) Regulation of Sestrin expression by oxidative stress. Although p53 is
essential for Sestrin1 expression after oxidative stress, it is dispensable for
induction of Sestrin2 and Sestrin3. While Nrf2 and AP-1 are required for
Sestrin2 induction, FoxO1 and FoxO3 are required for Sestrin3 induction upon
oxidative stress.
(B) Signaling pathways through which Sestrins control oxidative stress.
Sestrins can recycle peroxiredoxin (Prx) as a part of an oxidoreductase
enzyme complex that includes sulfiredoxin (Srx). Alternatively, Sestrins acti-
vate an antioxidant transcriptional program by stabilizing Nrf2 through removal
of its inhibitor Keap1. Sestrin-induced AMPK activation can lead to activa-
tion of PPARg coactivator 1a (PGC1a), resulting in increased mitochondrial
biogenesis, whereas Sestrin-mediated AMPK activation can lead to upregu-
lation of autophagy that removes dysfunctional mitochondria (mitophagy).
Through these activities, Sestrins decrease ROS accumulation and stimulate
antioxidant defenses.
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reactive carbonyl species, lipid peroxidation products, and
DNA alkylating agents. Excessive genotoxic damage during
metabolic stress can activate DNA damage-sensing signaling
pathways, including upregulation of tumor suppressor p53,
which exerts cell-cycle-inhibitory and proapoptotic activities
as well as affecting metabolic regulation. Sesn1 (also known as
PA26), the founding member of the Sestrin family, was originally
discovered as a p53-inducible gene (Velasco-Miguel et al.,
1999). Different challenges, including gamma irradiation, UV,
and genotoxic metabolites, stimulate transcription of the Sesn1
and Sesn2 genes through p53 (Budanov et al., 2002; Velasco-
Miguel et al., 1999). Activation of p53 by Nutlin-3, a drug that
disrupts the inhibitory association between Mdm2 and p53,
can lead to induction of Sesn1 and Sesn2 without DNA damage
(Budanov and Karin, 2008). p53 is also involved in Sesn2 regu-
lation by the orphan nuclear receptor TR3/Nur77 (Lee et al.,
2012b). Correspondingly, p53-responsive cis-elements were
identified in the first and second introns of the Sesn1 gene
(Velasco-Miguel et al., 1999; Wei et al., 2006) and in the first
exon and 9.6 kb downstream of the Sesn2 gene (Lee et al.,
2012b; Wei et al., 2006). In addition to the genotoxic challenges,
paclitaxel-induced mitotic block can also induce Sesn1 and
Sesn2 through an unknown mechanism (Rocha et al., 2011).Hypoxia, Energy Deficiency, and Desiccation
Hypoxia, insufficient oxygen availability, is one of the most se-
vere metabolic insults. Sesn2 (also known as Hi95) was originally
isolated as a gene activated by hypoxia in human neuroblastoma
cells (Budanov et al., 2002). In many human cancer cell lines,
hypoxia mimetics upregulate the expression of both Sesn1 and
Sesn2. Although Sesn1 is activated strictly in a p53-dependent
manner, transcriptional activation of Sesn2 upon hypoxia is
p53 independent (Budanov et al., 2002), but is hypoxia-inducible
factor-1 (HIF-1)-dependent in mouse epithelial tracheal cells
(Olson et al., 2011). However, in many other cell types, Sesn2
is induced upon hypoxia independently of HIF-1 and shows
expression kinetics that are distinct from other HIF-1 target
genes (Budanov et al., 2002). Presumably, in most cases,
Sesn2 transcription is induced not by hypoxia itself but as a
consequence of energy deprivation caused by prolonged
hypoxia. Many compounds that decrease cellular ATP concen-
tration, such as 2-deoxyglucose (inhibitor of glycolysis) and
metformin (inhibitor of mitochondrial respiration), induce Sesn2
expression via a mechanism that is yet to be established (Ben-
Sahra et al., 2013a). Interestingly, Belgica antarctica, the only
insect residing in Antarctica, strongly upregulates Sesn expres-
sion in response to desiccation, which is considered to be
critical for survival of this species in the freezing Antarctic climate
(Teets et al., 2012).
Oxidative Stress
Oxidative stress reflects an imbalance in ROS and RNS meta-
bolism and impairment of the cell’s ability to detoxify ROS,
RNS, and other reactive metabolic intermediates. All members
of the Sestrin family are induced by oxidative stress, although
they are subject to different induction mechanisms (Figure 1A)
(Budanov et al., 2004; Hagenbuchner et al., 2012; Nogueira
et al., 2008). Sesn1 is induced by hydrogen peroxide in a p53-
dependent manner, whereas induction of Sesn2 by oxidative
stress is only partially p53 dependent (Sablina et al., 2005). In
neurons, Sesn2 is induced upon N-methyl-D-aspartate (NMDA)
receptor activation, which stimulates the production of ROS, in
a CCAAT/enhancer binding protein-beta (c/EBPb)-dependent
manner (Papadia et al., 2008). More recently, oxidative stress
was found to induce Sesn2 via activation of transcription factor
Nrf2 (Shin et al., 2012) and via the JNK-AP-1 signaling axis
(Zhang et al., 2013). Binding sites for c/EBPb, Nrf2, and AP-1
are all present in the Sesn2 promoter region. Sesn3 is stimulated
by oxidative damage via activation of FoxO transcription factors
(Chen et al., 2010; Hagenbuchner et al., 2012). Similarly, dSesn is
regulated by a JNK-dFoxO signaling axis in response to chronic
dTORC1-induced oxidative stress in Drosophila (Lee et al.,
2010).
Hypernutrition, Obesity, and Chronic mTORC1
Activation
Hypernutrition and lack of exercise promote development of
obesity and the metabolic syndrome, both of which have
become very prevalent in modern societies. We observed that
Sesn2 is uniquely induced upon obesity in multiple mouse
tissues, including liver and skeletal muscle (Lee et al., 2012a).
Although the mechanism of this induction response is currently
elusive, it is plausible that chronic mTORC1 activation, which
is associated with hypernutrition, is involved. It has been pre-
viously shown in Drosophila that hyperactive dTORC1 resultsCell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc. 793
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way (Lee et al., 2010). In several human cancer cell lines, condi-
tions that lead to chronic mTORC1 activation, such as prolonged
treatments with insulin, insulin-like growth factor 1 (IGF1), or
serum, also lead to increased Sesn2 expression (A.V.B., unpub-
lished data). However, the mechanism of mammalian Sesn2
induction upon mTORC1 activation can be different from
the one responsible for dSesn induction. For instance, unlike
dSesn, the only mTORC1-inducible Sesn2 is not regulated by
FoxOs in mammalian cells, whereas Sesn1 and Sesn3, which
are not induced upon chronic mTORC1 activation or obesity
(Lee et al., 2012a), are FoxO targets (Chen et al., 2010; Greer
and Brunet, 2005). Therefore, alternative transcription factors
and signaling pathways are likely to be involved in obesity- and
chronic mTORC1-mediated Sesn2 induction in mammalian
cells.
Sestrins and Oxidative Metabolism
As described above, all members of the Sestrin family are
induced by oxidative stress, which implicates their involvement
in the metabolism of ROS and other reactive metabolites.
Silencing any of Sesn1, Sesn2, or Sesn3 by shRNA causes
accumulation of ROS in various cell lines (Budanov et al., 2004;
Nogueira et al., 2008), leading to DNA damage and chromo-
somal instability (Kopnin et al., 2007; Sablina et al., 2005) or
cell death (Budanov et al., 2002, 2004; Hagenbuchner et al.,
2012; Nogueira et al., 2008). Inactivation of dSesn in Drosophila
causes ROS accumulation and oxidative cell damage in skeletal
muscle (Lee et al., 2010). Importantly, a small conserved region
of the Sestrins (100–175 amino acids [aa] in Sesn1) shows
distant, but traceable, sequence homology to Mycobacterium
tuberculosis AhpD protein (Budanov et al., 2004). AhpD is a
critical component of the bacterial antioxidant defense system
that regenerates overoxidized AhpC, a bacterial peroxiredoxin
(Prx), through catalytic reduction. Similar to AhpD, the Sestrins
interact with and promote regeneration of overoxidized Prx in
mammalian cells (Budanov et al., 2004). Although the Sestrins
do not exhibit direct catalytic activity toward Prx that leads to
its reduction (Woo et al., 2009), they may promote the activity
of other oxidoreductases, such as sulfiredoxin (Srx), that also
regenerate Prx. Indeed, one recent study showed that Sestrins
can increase Srx expression through activation of Nrf2 (Fig-
ure 1B) (Bae et al., 2013). Sestrin-dependent regulation of Prx
is important for antioxidant defense in neurons and macro-
phages (Essler et al., 2009; Papadia et al., 2008).
Independently of their Prx-regulating activity, the Sestrins
contribute to redox homeostasis through regulation of the
AMPK/mTORC1 signaling pathway. Sestrins prevent mTORC1
hyperactivation that stimulates ROS production through its
effects on metabolism and mitochondrial function (Lee et al.,
2010). Sestrin-dependent activation of AMPK and suppression
of mTORC1 activity are critical for maintaining basal autophagy
(Maiuri et al., 2009). Thus, Sestrins can be important for auto-
phagic elimination of dysfunctional mitochondria that leak
electrons and produce pathogenic amounts of ROS (Ishihara
et al., 2013). Correspondingly, dSesn deficiency in Drosophila
results in accumulation of abnormal, ROS-producing mito-
chondria in skeletal muscle (Lee et al., 2010). Importantly, ROS
accumulation can be suppressed by a mutant dSesn that is794 Cell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc.unable to regenerate Prx but is able to inhibit mTORC1,
indicating that this property of the Sestrins is mediated through
their effect on mTORC1. Indeed, ROS accumulation in Sestrin-
deficient muscle was alleviated by pharmacological mTORC1
inhibitors (Lee et al., 2010). Sestrin-dependent inhibition of
mTORC1 can be also important for autophagy-mediated degra-
dation of Keap1, an inhibitor of Nrf2-dependent antioxidant
gene expression (Bae et al., 2013). A recent report also demon-
strated that, through AMPK activation, Sestrin2 can inhibit
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
4 (NOX4) that generates pathogenic amounts of cytosolic
ROS (Eid et al., 2010, 2013). These findings suggest that the
AMPK-mTORC1-regulating activity of Sestrins may be more
physiologically significant than their Prx-regulating activities in
preventing excessive ROS accumulation.
The Sestrins were also shown to mediate the antioxidant
activities associated with the p53 and FoxO transcription factors
(Hagenbuchner et al., 2012; Nogueira et al., 2008; Sablina et al.,
2005). While high levels of oxidative stress can lead to cell death
through p53- and FoxO-dependent apoptotic gene transcrip-
tion, low levels of oxidative stress cause moderate activation
of p53 and FoxO that can induce Sestrins to reduce oxidative
stress and prevent cell death. Thus, Sestrins are important
genetic components of a regulatory circuit that attenuates the
detrimental consequences of oxidative stress and ensures cell
viability and function. Sestrin2-mediated oxidative stress sup-
pression can also be important for other physiological pro-
cesses, as one recent study suggests that Sestrin2’s antioxidant
function is important for decreasing neuropathic pain; Sesn2/
mice exhibited highly increased neuropathic pain behavior after
peripheral nerve injury, which was suppressible by antioxidant
administration (Kallenborn-Gerhardt et al., 2013). Nevertheless,
the exact role of Sestrins in oxidative stress adaptation still
awaits more studies to be conducted with Sestrin-deficient
mouse models.
Sestrins and Nutrient Signaling
AMPK and mTORC1 are important nutrient-sensing protein
kinases that have diametrically antagonistic functions in meta-
bolic homeostasis (Hardie et al., 2012; Zoncu et al., 2011).
AMPK phosphorylates diverse anabolic enzymes, such as
acetyl-coenzyme A (CoA) carboxylase (ACC), glycerol phos-
phate acyl transferase (GPAT), 3-hydroxy-3-methylglutaryl
CoA reductase (HMGCR), and glycogen synthase (GS), directly
inhibiting their enzymatic activities in glycogen and lipid bio-
synthesis (Hardie et al., 2012). In addition to modulating these
traditional target enzymes, AMPK inhibits the transcriptional
activity of sterol regulatory element binding protein (SREBP)
through direct phosphorylation, thereby decreasing lipogenic
gene expression (Li et al., 2011). On the other hand, AMPK can
phosphorylate and activate autophagy-initiating protein kinases
ULK1 and ULK2, stimulating cellular autophagic catabolism
(Egan et al., 2011; Kim et al., 2011). Importantly, AMPK can
also inhibit mTORC1 activity through phosphorylation-depen-
dent activation of tuberous sclerosis complex 2 (TSC2) and
subsequent inhibition of the mTORC1-activating guanosine
triphosphatase (GTPase) Rheb (Inoki et al., 2003). Another report
shows that AMPK can directly inhibit mTORC1 through phos-
phorylation-dependent inhibition of its regulatory subunit Raptor
Figure 2. Regulation of Nutrient-Sensing Signaling Pathways
by Sestrins
Sestrins control metabolism through AMPK and mTORC1. Sestrins potentiate
AMPK activation and thereby suppress mTORC1 activity, leading to inhibition
of cellular anabolism and augmentation of catabolic processes such as
beta-oxidation and autophagy. TBC1D1, TBC1 domain family member 1;
GS, glycogen synthase; CRTC2, CREB-regulated transcription coactivator
2; PFKFB, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; ACC2,
acetyl-coA carboxylase 2; HMGCR, HMG-CoA reductase; CAD, carbamoyl-
phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase.
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cellular catabolism of sugar, protein, and lipids while inhibiting
anabolism.
In contrast to AMPK, mTORC1 activates anabolic processes
while inhibiting catabolic processes. mTORC1 promotes protein
translation by regulating its well-characterized substrates, such
as p70 S6 kinase (S6K) and eukaryotic translation initiation factor
4E-binding protein (4E-BP) (Zoncu et al., 2011). mTORC1 can
also boost cellular lipid synthesis by activating SREBP, through
suppression of the SREBP inhibitor Lipin-1 (Peterson et al.,
2011). mTORC1 is also an important negative regulator of auto-
phagy that inhibits the autophagy-initiating ULK1 and ULK2
complexes by direct phosphorylation (Chan, 2009; Kim et al.,
2011). Recent studies suggest that mTORC1 can also stimulate
synthesis of pyrimidines, which can be used as building blocks
for nucleic acids (Ben-Sahra et al., 2013b; Robitaille et al.,
2013). Therefore, while subjected to AMPK-mediated suppres-
sion, mTORC1 stimulates anabolic processes that are antago-
nized by AMPK action. However, defects in the regulatory
network that modulates the AMPK-mTORC1 balance in cells
can lead to aberrant activation of mTORC1, culminating in
age- and obesity-associated metabolic pathologies (Howell
and Manning, 2011).
When induced in response to stress, Sestrins inhibit mTORC1
through activation of AMPK (Figure 2) (Budanov and Karin,
2008). Consequently, Sestrin-deficient cells and tissues exhibit
lower AMPK and higher mTORC1 activities under both normal
and stressed conditions (Budanov and Karin, 2008; Lee et al.,
2010; Wempe et al., 2010). In mammalian cells, Sestrin2 is found
within a high-molecular-weight protein complex containing
TSC1, TSC2, and AMPK (Budanov and Karin, 2008). Although
it is not yet clear how the Sestrins activate AMPK, it has been
suggested that Sestrin2 can bring an upstream kinase LKB1and regulatory AMPKb and AMPKg subunits to the catalytic
AMPKa subunit, thereby facilitating LKB1-dependent activatory
Thr172 phosphorylation of AMPKa (Sanli et al., 2012). However,
Sestrin2-dependent AMPK activation was also observed in
LKB1-deficient cells, such as HeLa cells (W. Wang and M.K.,
unpublished data), suggesting that Sestrin-induced AMPK acti-
vation can also be LKB1 independent.
Through regulation of the AMPK-mTORC1 signaling axis, the
Sestrins promote metabolic adaptation of cells in response to
diverse stress insults. Sesn1 and Sesn2, as p53-inducible genes,
mediate DNA damage-induced activation of AMPK and sup-
pression of mTORC1 (Budanov and Karin, 2008). Sesn1 and
Sesn2 are also responsible for mitotic arrest-induced AMPK
activation and mTORC1 inhibition (Rocha et al., 2011). The
inhibition of mTORC1 activity leads to hypophosphorylation of
S6K and 4E-BP, ultimately resulting in cessation of protein syn-
thesis. Thus, Sesn1 and Sesn2 are essential for p53-mediated
suppression of protein translation during genotoxic stress
(Braunstein et al., 2009; Loayza-Puch et al., 2013). Induction of
Sesn2 upon genotoxic stress can also promote autophagic
catabolism, probably through the regulation of AMPK-mTORC1,
enabling cells to obtain extra nutrients and energy sources
(Maiuri et al., 2009). Both of these effects may be critical for
suppressing cell growth during genotoxic stress and for chan-
neling the saved energy to the DNA repair machinery, thereby
promoting the survival of stressed cells. Similarly, Sesn3, as a
FoxO-inducible protein, was shown to mediate oxidative
stress-induced suppression of mTORC1 and be required for
the maintenance of cellular energy stores during oxidative chal-
lenge (Chen et al., 2010). It was also shown that overexpressed
Sesn1 and Sesn2 can protect cells from oxidative stress- and
hypoxia-induced cell death (Budanov et al., 2002, 2004). There-
fore, the Sestrins can be viewed as stress-inducible regulators
of cellular metabolism that ensure cell survival under stressful
conditions.
At the organismal level, Sestrins’ roles in metabolic regulation
are not limited to acute stresses. In Drosophila, dSesn acts as a
physiological feedback regulator of dTORC1 that suppresses
various age-associated metabolic pathologies (Lee et al.,
2010). Loss of dSesn causes moderate downregulation of
AMPK and upregulation of dTORC1 in the fat body, thus leading
to increased expression of mRNAs encoding lipogenic enzymes,
ultimately resulting in triglyceride accumulation. This excessive
fat accumulation can be suppressed by pharmacological activa-
tion of AMPK and inhibition of dTORC1. Similarly in mice, Sesn2,
as an obesity-inducible Sestrin, was found to be an important
suppressor of liver fat accumulation (hepatosteatosis) upon die-
tary or genetically induced obesity (Lee et al., 2012a). Sesn2 also
suppresses acute hepatosteatosis induced by short-term
feeding with a high-carbohydrate diet after prolonged fasting
(Bae et al., 2013). Hepatosteatosis in the Sesn2-deficient mouse
liver is associated with decreased beta-oxidation of lipids as well
as with reduced mitochondrial mass and diminished hepatic
autophagy. Sesn2 was also found to regulate SREBP-1 activity;
however, hepatic de novo lipogenesis did not change very
much upon loss of Sesn2. Importantly, hepatosteatosis in
Sesn2-deficient mice can be corrected by pharmacological or
virus-mediated restoration of AMPK activity, supporting a role
for AMPK as a major mediator of Sestrin effects on metabolismCell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc. 795
Figure 3. Regulation of Insulin Signaling by Sestrins
Sestrin-enhanced activation of AMPK liberates insulin signaling from
mTORC1-mediated inhibitory effects. CR, caloric restriction; InR, insulin re-
ceptor; IRS, insulin receptor substrate; PDK1, phosphoinositide-dependent
kinase 1; Grb10, growth factor receptor-bound protein 10.
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tant for liver lipid homeostasis.
Although Sestrin-dependent regulation of protein synthesis
through mTORC1 can also be important for the control of cell
growth and proliferation, the Sestrins do not seem to act as
bona fide cell growth regulators. Neither dSesn deficiency in
Drosophila nor Sesn2 or Sesn3 deficiency in mice results in
increased body size or cell or tissue growth (Bae et al., 2013;
Lee et al., 2010, 2012a). Nevertheless, the Sestrins’ role in
protein metabolism and cell growth can still be detected under
conditions ofmTORC1 hyperactivation, when Sestrin expression
is induced. For example, in Drosophila, dSesn suppresses
hyperactive dTORC1-induced phosphorylation of dS6K and
d4E-BP and subsequent tissue overgrowth (Lee et al., 2010).
Moreover, Sesn2 suppresses cell growth and proliferation in
many cancer cell lines (Budanov et al., 2002; Budanov and Karin,
2008). Therefore, it is plausible that Sestrin-dependent regula-
tion of protein synthesis and cell growth can be important only
in the context of hyperactive mTORC1, for instance during
tumorigenesis, which will be further discussed below. Collec-
tively, these results show that Sestrins are evolutionarily
conserved regulators of protein and lipid metabolism acting
through the AMPK-mTORC1 signaling axis.
Sestrins Prevent Insulin Resistance and Diabetes
One of the most serious metabolic pathologies associated with
chronic mTORC1 activation is insulin resistance and type II dia-
betes (Howell and Manning, 2011; Zoncu et al., 2011). Through
its substrate S6K, mTORC1 activation results in inhibitory
phosphorylation of insulin receptor substrates (IRSs), thereby
contributing to attenuation of insulin-induced phosphatidylinosi-
tol 3-kinase (PI3K)/AKT signal transduction and subsequent
development of insulin resistance (Figure 3) (Um et al., 2004).
Recently, it was found that mTORC1 also phosphorylates and
activates growth factor receptor-bound protein 10 (Grb10),796 Cell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc.which acts as an inhibitor of the insulin-activated PI3K/AKT
signaling pathway (Hsu et al., 2011; Yu et al., 2011). mTORC1-
activated S6K also phosphorylates and inhibits Rictor, a
component of the mTORC2 complex that is critical for AKT
activation (Julien et al., 2010; Treins et al., 2010). Chronic inhibi-
tion of autophagy in liver, which can be caused by prolonged
mTORC1 activation, attenuates insulin signaling and induces
insulin resistance (Yang et al., 2010). Prolonged mTORC1 acti-
vation in hepatocytes can also induce chronic endoplasmic re-
ticulum (ER) stress (Ozcan et al., 2008), which can additionally
contribute to development of insulin resistance (Ozcan et al.,
2004). Thus, persistent activation of mTORC1 in response to
prolonged hypernutrition can give rise to insulin resistance,
elevate blood glucose, and eventually drive the pathogenesis
of type 2 diabetes.
Importantly, during obesity and also under normal conditions,
Sesn2 and Sesn3 in mice and dSesn in Drosophila were all
shown to be critical for maintenance of blood sugar homeostasis
(Lee et al., 2012a). Sesn2, whose expression in liver is induced
upon hypernutrition, is especially important for inhibition of
chronic mTORC1 and suppression of insulin resistance in hepa-
tocytes. Sesn2 is also important for the maintenance of insulin
responsiveness in adipose tissue. Consequently, Sesn2-defi-
cient mice exhibit impaired glucose homeostasis upon either
dietary or genetic obesity, which is mostly due to defects in
insulin-mediated suppression of hepatic glucose production.
Although Sesn2-deficient mice show no apparent defects in
glucose homeostasis on a normal chow diet, concomitant dele-
tion of Sesn2 and Sesn3 renders mice susceptible to sponta-
neous development of hepatic insulin resistance associated
with elevated hepatic mTORC1 activity, even without nutritional
overload or obesity. Similarly, dSesn null Drosophila exhibit an
elevated hemolymph trehalose level on a normal diet (Lee
et al., 2012a). These results indicate that Sestrin-dependent
regulation of blood sugar homeostasis is physiologically impor-
tant and evolutionarily conserved.
It has also been shown in diverse cultured cell lines that
Sestrins, including Sesn1, Sesn2, Sesn3, and dSesn, can poten-
tiate PI3K/AKT signal transduction even in the absence of
insulin (Lee et al., 2012a). Sestrin-induced activation of AKT is
dependent on AMPK, TSC2, and Rictor, suggesting that Sestrins
upregulate AKT signaling through AMPK and mTORC2. This
further suggests that Sestrins can modulate the balance of
signaling activity between mTORC1 and mTORC2 through
AMPK. Indeed, Sestrins potently inhibit the mTORC1/p70S6K
pathway while slightly upregulating the mTORC2/AKT pathway.
This very property differentiates the Sestrins from common
pharmacological mTOR inhibitors, such as rapamycin, Torin,
and PP242, which inhibit both mTORC1 and mTORC2 when
administered for a long term. Notably, pharmacological mTOR
inhibitors were found to be inappropriate for treatment of
obesity-associated diabetes and other metabolic pathologies
because they promote insulin resistance through mTORC2 inhi-
bition (Lamming et al., 2012). Therefore, modulation of Sestrin
activity may provide an alternative approach to prevention of
obesity, insulin resistance, and diabetes through attenuation of
mTORC1 and potentiation of mTORC2. These findings also sug-
gest that endogenous Sestrins are physiologically important in
keeping mTORC1 activity low and mTORC2/AKT activity high,
Table 1. Phenotypes of Sestrin-Modified Genetic Model Organisms
Organism Gene(s) Mutated Nature of Mutation(s) Context Phenotype Reference
C. elegans cSesn (Sesn-1
or Y74C9A.5)
loss of function normal aging reduced lifespan Yang et al., 2013
reduced locomotor activity
increased muscle ROS
muscle actin disorganization
bacterial infection normal resistance
oxidative stress (H2O2) reduced resistance
heat stress (35C) reduced resistance
heavy metal stress (CuSO4) reduced resistance
gain of function normal aging increased lifespan Yang et al., 2013
increased locomotor activity
decreased muscle ROS
oxidative stress (H2O2) increased resistance
heat stress (35C) increased resistance
heavy metal stress (CuSO4) increased resistance
Drosophila dSesn
(Sesn or CG11299)
loss of function normal aging less aggressivity Edwards et al., 2009
Lee et al., 2010increased fat accumulation
cardiac dilation
decreased/arrhythmic heartbeat
muscle degeneration
increased muscle ROS
protein aggregate formation
increased mTORC1 signaling
gain of function developing imaginal disc growth suppression Lee et al., 2010
decreased mTORC1 signaling
Mouse Sesn2 (Hi-95) loss of function normal aging normal body weight Lee et al., 2012a
normal glucose tolerance
normal insulin sensitivity
normal liver fat accumulation
normal mTORC1 signaling
nerve injury increased ROS accumulation Kallenborn-Gerhardt
et al., 2013increased neuropathic pain
mouse model of COPD reduced emphysema Wempe et al., 2010
increased ROS accumulation
increased mTORC1 signaling
reduced TGFb signaling
fasting reduced autophagy Bae et al., 2013
fasting/refeeding increased hepatosteatosis
increased ROS accumulation
increased liver damage
increased mTORC1 signaling
HFD-induced obesity body weight same as WT (con) Lee et al., 2012a
increased hepatosteatosis
increased glucose intolerance
increased insulin resistance
increased mTORC1 signaling
Lepob-induced obesity body weight same as WT (con)
increased hepatosteatosis
increased glucose intolerance
increased insulin resistance
(Continued on next page)
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Table 1. Continued
Organism Gene(s) Mutated Nature of Mutation(s) Context Phenotype Reference
increased mTORC1 signaling
Sesn2 & Sesn3 loss of function normal aging unaltered body weight Lee et al., 2012a
increased glucose intolerance
increased insulin resistance
increased mTORC1 signaling
Genetic studies done in C. elegans (Yang et al., 2013), Drosophila (Edwards et al., 2009; Lee et al., 2010), and mice (Bae et al., 2013; Kallenborn-Ger-
hardt et al., 2013; Lee et al., 2012a; Wempe et al., 2010) suggest that Sestrin-family proteins are critical for suppressing age- and obesity-associated
metabolic pathologies in diverse organ systems. COPD, chronic obstructive pulmonary disease; HFD, high-fat diet.
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bolic derangements.
Sestrins Attenuate Aging
Deregulated nutrient signaling, loss of protein homeostasis, and
accumulation of oxidative stress are hallmarks of aging (Lo´pez-
Otı´n et al., 2013). Activation of AMPK, suppression of mTORC1,
and stimulation of autophagic signaling were all shown to be
beneficial for extending both lifespan and healthspan (Gelino
and Hansen, 2012; Harrison et al., 2009; Mair et al., 2011; Miller
et al., 2011; Wilkinson et al., 2012). Thus, it seems plausible that
the antioxidant, AMPK-activating, mTORC1-suppressing, and
autophagy-inducing abilities of the Sestrins also contribute
to the attenuation of aging and suppression of age-associated
diseases. Indeed, Drosophila and mouse models of Sesn
deficiencies demonstrate that endogenous Sestrin activity is
required to prevent diverse age- and obesity-associated
pathologies. Inactivation of dSesn in Drosophila leads to chronic
suppression of AMPK and activation of mTORC1, resulting in fat
accumulation, blood sugar elevation, and skeletal and cardiac
muscle degeneration (Lee et al., 2010). As summarized in the
preceding sections, defective lipid and blood sugar homeosta-
sis, which are hallmarks of age-associated metabolic derange-
ments, are observed in both dSesn null Drosophila and Sesn2/
Sesn3-knockout mice (Lee et al., 2010, 2012a).
Notably, the cardiac and skeletal muscle phenotypes of the
dSesn null flies closely resemble the degenerative features of
age-associated myopathies and cardiomyopathies (Lee et al.,
2010). dSesn null flies show irregularity of heartbeat (arrhythmia),
cardiac dilation, and decreased heart rate, ultimately leading to
decreased cardiac function. The thoracic skeletal muscles of
dSesn null flies exhibit disorganized sarcomeric structure,
dysfunctional mitochondria, accumulation of protein aggre-
gates, and oxidative stress. Interestingly, similar deterioration
of cardiac and skeletal muscle is observed in flies with inactiva-
tion of ATG1, a critical regulator of autophagy, implying that
regulation of autophagy is at least one mechanism that contrib-
utes to dSesn’s myoprotective function (Lee et al., 2010). These
phenotypes observed in young dSesn or Atg1 mutant flies
(20 days old) are also similar to those typically seen in very
old wild-type (WT) flies (90 days old). Many of the detrimental
consequences of dSesn inactivation are prevented by treatment
with pharmacological AMPK activators or mTORC1 inhibitors,
suggesting that dSesn attenuates tissue aging through modu-
lation of the AMPK-mTORC1 axis (Lee et al., 2010). The degen-
erative muscle phenotypes were also exhibited by mutant798 Cell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc.C. elegans deficient in cSesn, suggesting that the role of Sestrins
inmuscle is evolutionarily conserved (Table 1) (Yang et al., 2013).
It is yet to be determined if the mammalian Sestrins are similarly
involved in cardiac and skeletal muscle homeostasis during
aging and other pathological conditions.
It should be noted that the DNA damage-sensing pathway
composed of ataxia telangiectasia mutated (ATM) and p53 is
important for expression of endogenous Sestrins and regulation
of metabolic homeostasis during aging. The p53Ser15Ala knockin
mouse, which shows dramatic downregulation of Sesn1, Sesn2,
and Sesn3 in liver, exhibits early-onset hepatic insulin resistance
and hyperglycemia (Armata et al., 2010). On the other hand,
p53-overexpressing mice, which have elevated Sesn1 and
Sesn2 expression in liver, show significantly increased longevity
and a delayed onset of age-associated metabolic pathologies
(Matheu et al., 2007). Although both studies attribute the meta-
bolic phenotypes to the modulation of Sestrins’ redox-regulating
activities, it shouldbeexaminedwhetherSestrin-dependent regu-
lationof theAMPK-mTORaxisprovidesabetter explanation to the
antidiabetic and antiaging activities of the ATM/p53 pathway.
Regardless of the molecular mechanisms operating downstream
of theSestrins, it is highly likely that theSestrinsmediate themeta-
bolic output of the DNA damage-sensing pathway, which is abro-
gated during tumorigenesis, aging, and metabolic pathologies.
Notably, current data from Drosophila and C. elegans indicate
that the association between Sestrins and lifespan is not as
strong as the antagonistic relationship between Sestrins and
age-associated pathologies. We and others observed that the
lifespan of dSesn null flies under normal conditions is not signif-
icantly different from that of WT flies (J.H.L. and M.K., unpub-
lished data; P. Kapahi, personal communication). The lifespan
of cSesn null worms was only slightly shorter than that of WT
worms (Yang et al., 2013). This weak association between
Sestrins and lifespan is in stark contrast to the robust linkage
between Sestrins and age-associated metabolic pathologies.
However, according to recent studies, most (if not all) of the
age-associated deaths in flies and worms are caused by, or
associated with, intestinal disintegration (McGee et al., 2011;
Rera et al., 2012). As Sestrins may not play major roles in regu-
lating intestinal barrier function, it is not very surprising that
Sestrin-deficient invertebrates show almost normal lifespan.
However, because Sestrin mutants show strong age-associated
pathologies in other metabolic organs, such as fat body, liver,
and skeletal and cardiac muscle in virtually all of the model
organisms examined, including C. elegans, Drosophila, and
mice, Sestrins can still be considered as important determinants
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mammals, the cause of age-related death is different from that
in invertebrates: cardiac dysfunction and malignant neoplasms
are the most significant causes of age-related death in humans.
Cardiac dysfunction in Drosophila is not immediately associated
with organismal death (Ocorr et al., 2007), and C. elegans even
does not have a distinct cardiac structure. Death caused by
malignancy also does not normally occur in flies or in worms.
Because Sestrins are suppressors of age-associated cardiac
pathologies and tumorigenesis, it is still plausible that Sestrins
regulate lifespan as well as healthspan in mammals.
Sestrins and Cancer
Advanced age is themajor risk factor for cancer. As a result, can-
cer is one of the most significant causes of age-related human
death. Cancer is a disease tightly linked to metabolic dysregu-
lation, oxidative stress, and genomic instability. Given that Ses-
trinsare important for suppressingoxidativedamage, inactivation
of Sestrins and accumulation of ROS and RNS might contribute
to carcinogenesis. Accordingly, silencing of Sestrins in cancer
cells stimulates mutagenesis, genomic instability, and growth of
tumor xenografts, features that are largely eliminated by antioxi-
dant treatment (Sablina et al., 2005). In addition, as suppressors
of mTORC1 activity, Sestrins can inhibit cancer cell growth and
thereforemay bepreferentially lost during tumorigenesis. Indeed,
Sesn1 and Sesn2 are generally downregulated in cancer, prob-
ably due to the inactivation of their master regulator p53
(Loayza-Puch et al., 2013). Constitutively active Ras oncogene
also downregulates Sesn1 and Sesn3 (Kopnin et al., 2007).
Although the mechanism of Ras-induced suppression has not
been determined, it has recently been shown that the transcrip-
tion factor heat shock factor protein 1 (HSF1) mediates Sesn3
regulation by Ras (Zamkova et al., 2013). Loss of heterozygocity
inSesn1 (6q21) andSesn2 (1p35) is alsooftenobserved in diverse
human cancers (Ragnarsson et al., 1999; Velasco-Miguel et al.,
1999). A mutation in the Sesn2 gene (Pro87Ser) was recently
identified as a cancer-driving mutation in myeloproliferative neo-
plasms through genome sequencing (Hou et al., 2012), although
how this mutation specifically affects Sestrin2 function is not yet
known. Another mechanism that can lead to Sestrin depletion
has been described in endometrial cancers where Sesn3 is
heavily methylated in 20% of tumors (Zighelboim et al., 2007).
Despite their involvement in tumor suppression and genome
protection, Sestrins are still expressed in many cancers (Buda-
nov et al., 2002) and might actually be required for maintaining
the viability of cancer cells under certain conditions. Very high
levels of oxidative stress, associated with chronic inflammation,
prolonged growth factor signaling, and dysfunctional mito-
chondria, can be detrimental for the survival and propagation
of cancer cells. For this reason, many cancer cells upregulate
the expression of antioxidant proteins, and Sestrins are part of
the antioxidant defense system. Another potential benefit to
keep Sestrin function intact is activation of autophagy (Ishihara
et al., 2013; Maiuri et al., 2009), which can support tumor growth
and metabolism during conditions of limited nutrient and oxygen
supply. Finally, Sestrin-dependent activation of mTORC2/AKT
(Lee et al., 2012a), a well-recognized oncogenic pathway, might
contribute to carcinogenesis through promotion of cancer cell
proliferation and survival.Being stress-responsive genes, Sestrins can also contribute
to the effects of cytotoxic anticancer therapies. Sestrins were
shown to promote DNA damage-induced cell death upon
irradiation and genotoxic drug treatments through a poorly
understood mechanism that may be related to the inhibition of
mTORC1 (Sanli et al., 2012). On the other hand, Sestrins may
hamper oxidative damage-associated chemotherapy by pro-
moting cancer cell survival (Budanov et al., 2002, 2004; Hagen-
buchner et al., 2012). Furthermore, it is also possible that hypox-
ia-induced Sesn2 may contribute to the well-known resistance
of hypoxic cancer cells to radiotherapy and chemotherapy.
Thus, the Sestrins might be important modulators of the
outcome of cancer therapy, although whether they are advanta-
geous or disadvantageous would have to be validated in various
cancer models. In any case, it is probable that Sestrins may
serve as predictive markers for the efficiency of cancer therapy
and help choose the best strategy for treatment. Modulation of
Sestrin expression or activity by small molecules might improve
the efficiency of radiotherapy or chemotherapy.
Unanswered Questions and Future Directions
Apparently, there are many remaining and unanswered ques-
tions regarding Sestrin biology and biochemistry. First and
foremost, the chemical basis of Sestrins’ antioxidant and
AMPK-activating/mTORC1-inhibiting activities should be clari-
fied. Elucidation of Sestrin structure and determination of critical
amino acid residues should be one of the first steps toward a
better understanding of the biochemical properties of Sestrin
proteins. These studies would also facilitate future development
of Sestrin-mimicking small molecules. Second, we need to
understand how Sestrin expression is regulated in response to
metabolic stressors, such as hypernutrition, energy depletion,
and ER stress. Third, the detailed molecular mechanisms
through which Sestrin induction normalizes metabolic derange-
ments during obesity and normal aging should be determined.
Fourth, the role of mammalian Sestrin1 needs to be genetically
determined. Because Sestrin1 is highly enriched in skeletal
muscle (Peeters et al., 2003), it is plausible that it may be analo-
gous to cSestrin and dSestrin in control of muscle homeostasis
(Lee et al., 2010; Yang et al., 2013). However, to test this hypo-
thesis, muscle-specific Sesn1-knockout mice are needed. It
would also be interesting to see if Sestrin1 and other mammalian
Sestrins are required for preventing cardiac pathologies, as in
Drosophila (Lee et al., 2010). Finally, it is important to determine
and evaluate the impact of mammalian Sestrins on the regulation
of aging, carcinogenesis, the metabolic syndrome, and other
diseases. The recently generated Sestrin-deficient mouse
strains would provide important tools for determining the role
of each Sestrin in diverse physiological contexts. Through these
future studies, we will be able to understand how Sestrins
regulate aging and metabolism in mammals and whether their
antioxidant function, effects on AMPK-mTORC1 signaling, or
some yet-to-be-defined activities are most important.
Conclusions
Chronic stress, metabolic derangements, and organ dysfunction
are hallmarks of aging, obesity, and their comorbidities. Formerly
discovered as stress-responsive and p53-regulated proteins, the
Sestrins are now recognized as important regulators ofCell Metabolism 18, December 3, 2013 ª2013 Elsevier Inc. 799
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Reviewmetabolism that ensure physiological homeostasis, suppression
of age- and obesity-associated diseases, muscle degeneration,
cardiac malfunction, and cancer. Consequently, the Sestrins
may be imminent therapeutic targets for attenuation of aging
and prevention of cancer and obesity-relatedmetabolic derange-
ments.
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